Therefore, the purpose of the present study was to confirm the potency of the effects of GIK using a rat model of intestinal mucosal barrier injury and to elucidate the association between GIK therapy and the expression of UCP2 in a CLP-induced sepsis model. This evidence concerns the gene UCP2 and Sepsis.